Drupal.behaviors.print = function(context) {window.print();window.close();}>

Rosetta Genomics Stock Surges on Lung Cancer Dx Findings

January 13, 2010

Rosetta Genomics Stock Surges on Lung Cancer Dx Findings

By a GenomeWeb staff reporter

A new study from Johns Hopkins and Rosetta researchers finds the miRview NSCLC test to be effective.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories